103 tracked 13F filers disclose a position in KYTX as of the latest SEC 13F filings, a combined $311.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | $36.6M | 4.2M | ▼−3.3% Reduced · −147K sh | Q1 2026 | |
| 2 | GILEAD SCIENCES, INC. | $35.6M | 4.1M | —Held | Q1 2026 | |
| 3 | Bain Capital Life Sciences Investors, LLC | $25.7M | 2.9M | ▼−7.2% Reduced · −225K sh | Q2 2026 | |
| 4 | AIGH Capital Management LLC | $24.9M | 2.8M | ▲+40% Added · +796K sh | Q2 2026 | |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. | $17.3M | 2.0M | —Held | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $15.4M | 1.8M | →First observed position No prior filed position | Q1 2026 | |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | $13.4M | 1.6M | ▼−12% Reduced · −207K sh | Q1 2026 | |
| 8 | BALYASNY ASSET MANAGEMENT L.P. | $9.7M | 1.1M | ▲+15% Added · +144K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $9.4M | 1.0M | ▲+148% Added · +626K sh | Q2 2026 | |
| 10 | MILLENNIUM MANAGEMENT LLC | $8.7M | 1.0M | ▲+69% Added · +412K sh | Q1 2026 | |
| 11 | Insight Holdings Group, LLC | $8.8M | 989K | —Held | Q2 2026 | |
| 12 | STATE STREET CORP | $8.8M | 982K | ▲+610% Added · +844K sh | Q2 2026 | |
| 13 | MORGAN STANLEY | $8.4M | 977K | ▼−2.5% Reduced · −25K sh | Q1 2026 | |
| 14 | BlackRock, Inc. | $7.6M | 877K | ▲+61% Added · +333K sh | Q1 2026 | |
| 15 | Woodline Partners LP | $7.3M | 845K | ▲~0% Added · +182 sh | Q1 2026 | |
| 16 | D. E. Shaw & Co., Inc. | $6.2M | 722K | ▲+39% Added · +203K sh | Q1 2026 | |
| 17 | MBB PUBLIC MARKETS I LLC | $5.3M | 614K | —Held | Q1 2026 | |
| 18 | MARSHALL WACE, LLP | $5.2M | 606K | ▲+347% Added · +470K sh | Q1 2026 | |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.0M | 578K | ▲+142% Added · +339K sh | Q1 2026 | |
| 20 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.3M | 500K | ▼−70% Reduced · −1.2M sh | Q1 2026 | |
| 21 | UBS Group AG | $3.9M | 450K | ▲+122% Added · +248K sh | Q1 2026 | |
| 22 | BNP PARIBAS FINANCIAL MARKETS | $3.6M | 412K | ▲+63% Added · +160K sh | Q1 2026 | |
| 23 | RENAISSANCE TECHNOLOGIES LLC | $3.2M | 367K | ▲+107% Added · +190K sh | Q1 2026 | |
| 24 | Qube Research & Technologies Ltd | $2.9M | 334K | ▲+425% Added · +270K sh | Q1 2026 | |
| 25 | Walleye Capital LLC | $2.2M | 246K | ▲+543% Added · +207K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 11 funds opened a new position in KYTX and 20 added to an existing one, while 18 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 53 funds | $56.6B |
| NVIDIA CORPNVDA | 51 funds | $127.2B |
| META PLATFORMS INC-CLASS AMETA | 51 funds | $37.0B |
| ELI LILLY & COLLY | 51 funds | $23.6B |
| COSTCO WHOLESALE CORPCOST | 51 funds | $12.3B |
| ALPHABET INC-CL AGOOGL | 50 funds | $51.6B |
| TESLA INCTSLA | 50 funds | $24.5B |
| LAM RESEARCH CORPLRCX | 50 funds | $9.4B |
| APPLE INCAAPL | 49 funds | $97.7B |
| MICROSOFT CORPMSFT | 49 funds | $78.0B |
| BROADCOM INCAVGO | 49 funds | $49.4B |
| MICRON TECHNOLOGY INCMU | 49 funds | $14.2B |
Ranked by how many of KYTX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 18, 2025 | Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | Buy (P) | 133K | $1000K |
| Dec 18, 2025 | SEIDENBERG BETH C | Director | Buy (P) | 133K | $1000K |
| Dec 15, 2025 | Walker Karen Marie | Chief Technology Officer | Sell (S) | 24K | $293K |
| Feb 12, 2024 | Northpond Ventures III GP, LLC | Insider | Buy (P) | 450K | $9.9M |
| Feb 12, 2024 | Bain Capital Life Sciences Fund III, L.P. | 10% Owner | Buy (P) | 450K | $9.9M |
| Feb 12, 2024 | Vida Ventures GP III, L.L.C. | 10% Owner | Buy (P) | 253K | $5.6M |
| Feb 12, 2024 | Vida Ventures GP III, L.L.C. | 10% Owner | Buy (P) | 583 | $13K |
| Feb 12, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy (P) | 910K | $20.0M |
Connected entities for KYTX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/KYTX/capital-change-brief"
Use Arkolith's capital_change_brief for KYTX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for KYTX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.